GFL Environmental Inc. (GFL)

ASLAN Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,360	17,520	12,806	10,033	12,704	9,505
Market Cap Growth	26.09%	36.81%	27.64%	-21.03%	33.65%	-
Enterprise Value	23,663	24,570	19,870	17,113	18,773	13,129
Last Close Price	50.47	44.50	34.42	29.11	37.64	28.98
PS Ratio	3.10	3.21	2.25	2.01	3.13	2.89
PB Ratio	3.17	3.49	2.29	2.25	2.78	2.17
P/FCF Ratio	132.90	72.60	-	41.01	64.13	163.89
P/OCF Ratio	17.99	16.37	17.25	12.39	17.90	24.12
EV/Sales Ratio	3.99	4.50	3.49	3.43	4.63	3.99
EV/EBITDA Ratio	17.02	17.82	14.55	14.47	17.76	17.81
EV/EBIT Ratio	54.98	68.50	67.42	156.49	79190.25	-
EV/FCF Ratio	171.30	101.82	-	69.95	94.76	226.38
Debt / Equity Ratio	0.91	1.46	1.26	1.60	1.46	1.17
Debt / EBITDA Ratio	3.62	5.06	4.94	5.78	6.04	6.68
Debt / FCF Ratio	37.92	30.38	-	29.23	33.55	88.29
Asset Turnover	0.42	0.38	0.38	0.35	0.30	0.30
Quick Ratio	0.55	0.44	0.70	0.45	0.87	0.75
Current Ratio	0.67	0.54	0.82	0.51	0.98	0.86
Return on Equity (ROE)	0.68%	-10.10%	0.48%	-3.10%	-11.05%	-26.44%
Return on Assets (ROA)	1.89%	1.57%	1.23%	0.48%	0.00%	-1.16%
Return on Capital (ROIC)	2.28%	1.87%	1.50%	0.62%	0.00%	-1.43%
Return on Capital Employed (ROCE)	3.50%	2.90%	2.20%	0.90%	0.00%	-
Earnings Yield	14.16%	-2.87%	0.27%	-2.30%	-3.77%	-9.10%
FCF Yield	0.75%	1.38%	-0.44%	2.44%	1.56%	0.61%
Dividend Yield	0.12%	0.13%	0.15%	0.17%	0.12%	0.14%
Payout Ratio	0.87%	-	55.07%	-	-	-
Buyback Yield / Dilution	-3.97%	-3.03%	-28.04%	20.15%	-0.33%	-99.61%
Total Shareholder Return	-3.85%	-2.90%	-27.89%	20.32%	-0.21%	-99.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q